Gnathostoma infection after ingestion of raw fish is a probable cause of eosinophilic meningitis in the Brazilian Amazon.

Autor: Graeff-Teixeira C; Universidade Federal do Espírito Santo, Núcleo de Doenças Infecciosas, Centro de Ciências da Saúde, Vitória, ES, Brasil., Pauli DS; Hospital Evangélico, Londrina, PR, Brasil., Zicarelli CAM; Hospital Evangélico, Londrina, PR, Brasil., Pascoal VF; Pontifícia Universidade Católica do Rio Grande do Sul, Escola de Ciências da Saúde e da Vida, Porto Alegre, RS, Brasil., Paiva-Novaes EP; Universidade Federal do Espírito Santo, Núcleo de Doenças Infecciosas, Centro de Ciências da Saúde, Vitória, ES, Brasil., Chagas JPS; Universidade Federal do Espírito Santo, Núcleo de Doenças Infecciosas, Centro de Ciências da Saúde, Vitória, ES, Brasil., Kersanach BB; Universidade Federal do Espírito Santo, Núcleo de Doenças Infecciosas, Centro de Ciências da Saúde, Vitória, ES, Brasil., Hadad DJ; Universidade Federal do Espírito Santo, Núcleo de Doenças Infecciosas, Centro de Ciências da Saúde, Vitória, ES, Brasil., Walger-Schultz LK; Escola Superior São Francisco de Assis, Santa Teresa, ES, Brasil.

Publikováno v: Revista da Sociedade Brasileira de Medicina Tropical [Rev Soc Bras Med Trop] 2024 Mar 04; Vol. 57, pp. e008012024. Date of Electronic Publication: 2024 Mar 04 (Print Publication: 2024).

TUMOR NEUROECTODÉRMICO PRIMITIVO (PNET) COM INVASÃO MACIÇA EM MEDULA ÓSSEA SIMULANDO LEUCEMIA AGUDA: RELATO DE CASO

Autor: Sipolatti, ALRAC, Alves, RMC, Matos, PADSBA, Marcondes, SS, Santos, MDD, Araújo, MP, Frechiani, JPA, Abreu, GR, Hadad, DJ, Belisário-Filho, V

Publikováno v: In Hematology, Transfusion and Cell Therapy October 2022 44 Supplement 2:S165-S166

Increase of CD4+CD25highFoxP3+ cells impairs in vitro human microbicidal activity against Mycobacterium tuberculosis during latent and acute pulmonary tuberculosis.

Autor: Stringari LL; Núcleo de Doenças Infecciosas, Universidade Federal do Espírito Santo, Vitória, Brazil., Covre LP; Núcleo de Doenças Infecciosas, Universidade Federal do Espírito Santo, Vitória, Brazil., da Silva FDC; Núcleo de Doenças Infecciosas, Universidade Federal do Espírito Santo, Vitória, Brazil., de Oliveira VL; Núcleo de Doenças Infecciosas, Universidade Federal do Espírito Santo, Vitória, Brazil., Campana MC; Núcleo de Doenças Infecciosas, Universidade Federal do Espírito Santo, Vitória, Brazil., Hadad DJ; Núcleo de Doenças Infecciosas, Universidade Federal do Espírito Santo, Vitória, Brazil., Palaci M; Núcleo de Doenças Infecciosas, Universidade Federal do Espírito Santo, Vitória, Brazil., Salgame P; Center for Emerging Pathogens, Rutgers-New Jersey Medical School, International Center for Public Health, Newark, New Jersey, United States of America., Dietze R; Núcleo de Doenças Infecciosas, Universidade Federal do Espírito Santo, Vitória, Brazil.; Global Health & Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal., Gomes DCO; Núcleo de Doenças Infecciosas, Universidade Federal do Espírito Santo, Vitória, Brazil.; Núcleo de Biotecnologia, Universidade Federal do Espírito Santo, Vitória, Brazil., Ribeiro-Rodrigues R; Núcleo de Doenças Infecciosas, Universidade Federal do Espírito Santo, Vitória, Brazil.

Publikováno v: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2021 Jul 29; Vol. 15 (7), pp. e0009605. Date of Electronic Publication: 2021 Jul 29 (Print Publication: 2021).

Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual patient data.

Autor: Barr DA; Institute of Infection and Global Health, University of Liverpool, Liverpool, UK; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Liverpool School of Tropical Medicine, Liverpool, UK. Electronic address: david.barr@liverpool.ac.uk., Lewis JM; Liverpool School of Tropical Medicine, Liverpool, UK; Malawi-Liverpool-Wellcome Clinical Research Programme, Queen Elizabeth Central Hospital, College of Medicine, Blantyre, Malawi., Feasey N; Liverpool School of Tropical Medicine, Liverpool, UK; Malawi-Liverpool-Wellcome Clinical Research Programme, Queen Elizabeth Central Hospital, College of Medicine, Blantyre, Malawi., Schutz C; Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Cape Town, South Africa; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Department of Medicine, University of Cape Town, Cape Town, South Africa., Kerkhoff AD; Division of HIV, Infectious Diseases, and Global Medicine at Zuckerberg San Francisco General Hospital and Trauma Center, Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Jacob ST; Liverpool School of Tropical Medicine, Liverpool, UK., Andrews B; Institute for Global Health, Vanderbilt University School of Medicine, Nashville, TN, USA., Kelly P; Blizard Institute, Barts and London School of Medicine, Queen Mary University of London, London, UK., Lakhi S; Department of Internal Medicine, University of Zambia School of Medicine and University Teaching Hospital, Lusaka, Zambia., Muchemwa L; Department of Internal Medicine, University of Zambia School of Medicine and University Teaching Hospital, Lusaka, Zambia; Defence Force School of Health Sciences, Lusaka, Zambia., Bacha HA; Instituto de Infectologia Emilio Ribas, São Paulo, Brazil., Hadad DJ; Universidade Federal do Espirito Santo, Centro de Ciêncicas da Saúde, Departamento de Clinica Médica, Vitoria, Brazil., Bedell R; Dignitas International, Zomba, Malawi; Division of Global Health, University of British Columbia, Vancouver, BC, Canada., van Lettow M; Dignitas International, Zomba, Malawi; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada., Zachariah R; Medecins Sans Frontieres, Operational Centre Brussels, Brussels, Belgium., Crump JA; Centre for International Health, University of Otago, Dunedin, New Zealand; Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, NC, USA; Kilimanjaro Christian Medical Centre, Moshi, Tanzania., Alland D; Division of Infectious Disease, Department of Medicine, Rutgers-New Jersey Medical School, Newark, NJ, USA., Corbett EL; Malawi-Liverpool-Wellcome Clinical Research Programme, Queen Elizabeth Central Hospital, College of Medicine, Blantyre, Malawi; London School of Hygiene and Tropical Medicine, London, UK., Gopinath K; Max Planck Institute for Infection Biology, Berlin, Germany., Singh S; Division of Clinical Microbiology and Molecular Medicine, All India Institute of Medical Sciences, New Delhi, India., Griesel R; Department of Medicine, University of Cape Town, Cape Town, South Africa., Maartens G; Department of Medicine, University of Cape Town, Cape Town, South Africa., Mendelson M; Division of Infectious Diseases and HIV Medicine, University of Cape Town, Cape Town, South Africa; Department of Medicine, University of Cape Town, Cape Town, South Africa., Ward AM; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Parry CM; Institute of Infection and Global Health, University of Liverpool, Liverpool, UK; Liverpool School of Tropical Medicine, Liverpool, UK; School of Tropical Medicine and Global Health, University of Nagasaki, Nagasaki, Japan., Talbot EA; Infectious Disease and International Health, Dartmouth Medical School, Hanover, NH, USA., Munseri P; Department of Internal Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Dorman SE; Johns Hopkins University Centre for TB Research, Johns Hopkins School of Medicine, Baltimore, MD, USA., Martinson N; Johns Hopkins University Centre for TB Research, Johns Hopkins School of Medicine, Baltimore, MD, USA; Perinatal HIV Research Unit, South African Medical Research Council Soweto Matlosana Collaborating Centre for HIV/AIDS and TB, Centre of Excellence for Biomedical TB Research, University of the Witwatersrand, Johannesburg, South Africa., Shah M; Johns Hopkins University Centre for TB Research, Johns Hopkins School of Medicine, Baltimore, MD, USA., Cain K; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Heilig CM; Center for Surveillance, Epidemiology, and Laboratory Services, Atlanta, GA, USA; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Varma JK; US Centers for Disease Control and Prevention, Atlanta, GA, USA., von Gottberg A; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa., Sacks L; Office of Medical Policy, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Wilson D; Department of Internal Medicine, Edendale Hospital, University of KwaZulu-Natal, Pietermaritzburg, South Africa., Squire SB; Liverpool School of Tropical Medicine, Liverpool, UK., Lalloo DG; Liverpool School of Tropical Medicine, Liverpool, UK., Davies G; Institute of Infection and Global Health, University of Liverpool, Liverpool, UK., Meintjes G; Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Cape Town, South Africa; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Department of Medicine, University of Cape Town, Cape Town, South Africa.

Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2020 Jun; Vol. 20 (6), pp. 742-752. Date of Electronic Publication: 2020 Mar 13.

Daily 800 mg versus 600 mg Efavirenz for HIV Patients Treating Tuberculosis with a Rifampicin-Based Regimen: An Open Label Randomized Controlled Trial.

Autor: Xavier MS; Plataforma de Pesquisa Clínica da Vice-Presidência de Pesquisa e Coleções Biológicas/Fiocruz, Brazil., Trajman A; Programa de Pós-Graduação em Clínica Médica, Universidade Federal do Rio de Janeiro, Brazil.; McGill University, Canada., Schmaltz CAS; Laboratório de Pesquisa Clínica em Micobacterioses do Instituto Nacional de Infectologia Evandro Chagas/Fiocruz, Brazil., Sant'anna FM; Laboratório de Pesquisa Clínica em Micobacterioses do Instituto Nacional de Infectologia Evandro Chagas/Fiocruz, Brazil., Maia IR; Plataforma de Pesquisa Clínica da Vice-Presidência de Pesquisa e Coleções Biológicas/Fiocruz, Brazil., Hadad DJ; Núcleo de Doenças Infecciosas, Universidade Federal do Espírito Santo, Brazil., do Brasil PEAA; Laboratório de Pesquisa Clínica em Imunizações e Vigilância do Instituto Nacional de Infectologia Evandro Chagas/Fiocruz, Brazil., Rolla V; Laboratório de Pesquisa Clínica em Micobacterioses do Instituto Nacional de Infectologia Evandro Chagas/Fiocruz, Brazil.

Publikováno v: BioMed research international [Biomed Res Int] 2018 Dec 25; Vol. 2018, pp. 9231835. Date of Electronic Publication: 2018 Dec 25 (Print Publication: 2018).